Surface immunoglobulin of B-lymphocytic tumours as a therapeutic target.

Abstract

The surface immunoglobulin of B-lymphocytic tumours is well characterized at the molecular level and in its idiotypic determinants offers antigenic targets which are effectively tumour-specific. Anti-idiotype antibodies raised individually for each tumour have been used for passive serotherapy in animals and man. The advent of monoclonal technology has… (More)

Topics

Cite this paper

@article{Stevenson1985SurfaceIO, title={Surface immunoglobulin of B-lymphocytic tumours as a therapeutic target.}, author={G. T. Stevenson and Martin J. Glennie}, journal={Cancer surveys}, year={1985}, volume={4 1}, pages={213-44} }